Pfizer to stop advertising Celebrex, stands by safety
30183
NEW YORK  - US drug giant Pfizer said it will stop advertising painkiller Celebrex after a trial indicated a heart-attack risk at high doses, but vowed to carry on sales.
725683
Pfizer Inc. said it found an increased risk of heart attacks and strokes for patients taking high dosages of its top-selling arthritis painkiller Celebrex -- the same problem that led to the withdrawal of its one-time competitor, Vioxx.
459276
Pfizer said today that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to further assess the cardiovascular safety of the drug.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
223257
Pfizer Inc. has agreed to suspend  its advertisements for arthritis drug Celebrex while U.S.  regulators review new data that link the drug to an elevated  risk of heart attacks, a Food and Drug Administration  spokeswoman said on Sunday.
69221
Although advertising will be suspended indefinitely, Pfizer plans to continue marketing Celebrex to doctors.
21205
WASHINGTON, Dec 23  - US regulators called Thursday for use of Pfizer&#39;s painkilling drugs Celebrex and Bextra to be limited, urging doctors to keep in mind indications of higher heart attack and stroke risks.
548822
NEW YORK/OTTAWA  - Pfizer Inc. PFE.N said on  Thursday its arthritis drug Celebrex was safe after a report in  a Canadian newspaper linked it to 14 deaths,
365287
Kaiser Permanente has stopped dispensing Bextra, an arthritis and pain drug made by Pfizer that may increase the risk of heart attacks and strokes.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
157889
Description: Pfizer will stop advertising the painkiller Celebrex after discussions with the Food and Drug Administration. A study linked Celebrex to an increased risk of heart problems, but the company plans to keep it on the market.
227257
Pfizer Inc. said Friday that it found an increased risk of heart attacks and strokes for patients taking high dosages of its top-selling arthritis painkiller Celebrex, the same
307761
There&#39;s a reason you knew of Celebrex, even before the recent news about its related health warnings: those commercials, with the chorus of &quot;Celebrate, celebrate!
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.
659779
GAITHERSBURG, Maryland  - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children, a U.S. advisory panel said in a 15-1 vote on Wednesday despite concerns about the drug's long-term safety.
572357
Pfizer Inc. said on Thursday its arthritis drug Celebrex is safe. Its comments followed a report in a Canadian newspaper that raised concerns the drug may have been linked to 14 deaths.
335553
Pfizer Inc. said it has found an increased risk of heart attacks with patients taking its top-selling painkiller Celebrex, a drug that is in the same class as Vioxx, but has no plans to remove it from the market.